Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment

Published:2024-04-26 Issue:6 Volume:51 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Yu Zhongjie¹,Shi Jianhua²,Fang Yuan³,Zhao Yi¹,Xu Aotian¹,Li Ning³

Affiliation:

1. R&D, Qingdao Sino‑cell Biomedicine Co., Ltd., Qingdao, Shandong 266000, P.R. China

2. Phase Ⅰ Clinical Research Center Affiliated, Linyi Tumor Hospital, Linyi, Shandong 276000, P.R. China

3. Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China

Publisher

Spandidos Publications

Reference81 articles.

1. Cancer statistics in China, 2016;Zheng;Zhonghua Zhong Liu Za Zhi,2023

2. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

3. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050;Chen;JAMA Oncol,2023

4. CAR-T cell therapy: Current limitations and potential strategies;Sterner;Blood Cancer J,2021

5. Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors;Wang;BMC Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP